Results 141 to 150 of about 677,625 (318)
The placebo effect in our everyday lives
reservedSpesso le nostre scelte di vita quotidiana sono governate da delle forze a noi estranee che inconsapevolmente influiscono sul nostro comportamento.
GENOVESI, MARTA
core
Journal of Applied Polymer Science, EarlyView.This review highlights the synthesis of chitosan nanoparticles from natural sources, the thorough characterization of them, and use of microscopic and spectroscopic methods. It emphasizes that it has some indispensable properties such as being non‐toxic, antimicrobial, and capable of controlled drug release.
Mariam Sohail Mansoor +6 more
wiley +1 more source
reservedQuesto studio analizza l’efficacia del placebo nel trattamento fisioterapico del dolore lombare cronico, esplorando i meccanismi neurofisiologici coinvolti. Vengono esaminati i processi che avvengono a livello cerebrale e i fattori favorevoli che
BIGARELLA, MATTEO
core
Cytokine Pathways Driving Diverse Tissue Pathologies in Rheumatoid Arthritis
Arthritis &Rheumatology, EarlyView.Rheumatoid arthritis (RA) is a complex systemic disorder characterized primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease, such as that of the lung, with potentially devastating clinical consequences. The critical importance of comorbidities,
Aurelie Najm +2 more
wiley +1 more source
Placebo Effect: a support for learning disabilities?
reservedL'elaborato affronta il tema dell'effetto placebo e come questo può essere un supporto per gli studenti con disturbi specifici dell'apprendimento.
COCCO, GAIA
core
Arthritis &Rheumatology, EarlyView.Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley +1 more source
Arthritis &Rheumatology, EarlyView.Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro +17 more
wiley +1 more source
Arthritis &Rheumatology, EarlyView.Objective Our study objective was to identify serum protein signatures associated with progression to rheumatoid arthritis (RA) and response to abatacept in at‐risk individuals. Methods A total of 440 serum samples from 118 APIPPRA (Arthritis Prevention In the Preclinical Phase of RA with Abatacept) study participants were selected from baseline to RA ...
Marianna Jasenecova +9 more
wiley +1 more source